Validation of medical technologies in the context of care


LAVAL, QC, May 30, 2022 /CNW Telbec/ – The Center québécois d’innovation en biotechnologie (CQIB) is proud to announce the creation of a new consortium whose mission is to accelerate the validation of technology in real care conditions, while young Quebec companies face significant challenges in validating the technologies developed in the Quebec health network. In the long term, the consortium’s support will facilitate the commercialization and export of of Quebec expertise in health technologies and generate investments close to $100 million.

As part of of Quebec new life sciences strategy, the consortium of seven incubators and accelerators will be led by the Center d’innovation en biotechnologie du Québec and will be supported by $2 million in financial assistance from the Ministry of Economy and Innovation of Quebec.

Market entry support

This program aims to respond to the difficulty for young life sciences companies to access clinicians, doctors and health professionals to carry out the last stage of the technical-commercial validation of an innovation in the real context. care. More concretely, this consortium will allow Quebec start-ups to be competitive with the biggest players in the industry and thus penetrate the international market.

Besides the CQIB, the other members of the Consortium are Admare BioInnovations, Centech, District 3, CTS, ACET and QuantINO.


Our government wants to stimulate business and increase private investment in the life sciences so that the industry can operate to its full potential. This financial support will enable members of the Consortium of accelerators and incubators to improve support for young companies in the sector, increase the marketing of Quebec innovations and attract investment in research and development.

– Mr. Peter FitzgibbonMinister of Economy and Innovation

“This new three-year program will allow us to continue our mission of encouraging the development of young people Quebec companies working in the life sciences. Marketing in the healthcare system requires a lot of effort and in-depth knowledge of the industry. So the role of the consortium will be to facilitate this process.”

– Perry Niro, Executive Director of the Center québécois d’innovation en biotechnologie (CQIB) and responsible for managing the fund on behalf of the members of the Consortium.

About the CQIB and the members of the Consortium

The CQIB is an incubator whose mission is to facilitate the creation, growth and success of the next generation of life science and health technology companies. It offers its space to start-up companies requiring access to laboratories and scientific equipment as well as expertise in the development of business projects.

Since its creation, the entire Consortium of Life Sciences Accelerators and Incubators has generated close to $1 billion in investment.

SOURCE Quebec Center for Biotechnology Innovation (CQIB)

For further information: Jessica Rousseau, TACT, Cell: 438 396-8288, [email protected]; Perry Niro, Executive Director, Quebec Center for Biotechnology Innovation, [email protected], Cell. : (514) 265-8944


Comments are closed.